Equities research analysts at HC Wainwright increased their Q1 2025 earnings estimates for Atossa Therapeutics in a note ...

Atossa Genetics (ATOS) might move higher on growing optimism ... Just because a business does not make any money, does not mean that the stock will go down. For example, although ...

Atossa Therapeutics (NASDAQ:ATOS – Get Free Report) will likely be posting its quarterly earnings results on Tuesday, March ...

Atossa Genetics Inc. (ATOS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- ...

ATOSSA GENETICS ($ATOS) posted quarterly earnings results on Tuesday, March 25th. The company reported earnings of -$0.05 per share, beating estimates of -$0.06 by $0 ...

Short interest in Atos SE (OTC:AEXAF ... of this short interest to close out their positions without sending the stock sharply higher.

Paris, France - March 7, 2025. – Atos SE (the “Company”) announces the implementation of a reverse stock split of the shares comprising its share capital, through the exchange of 10,000 old ...

The stock split will start on March 25 and will end on April 23, Atos said in a statement. The company is consolidating its ...

Atos shares fell sharply in early European trading, despite making initial gains, after the French IT company said it would launch a reverse stock split. Shares in Paris were volatile, trading 8.2 ...

Paris, France - March 7, 2025. – Atos SE (the “Company”) announces the implementation of a reverse stock split of the shares comprising its share capital, through the exchange of 10,000 old shares of ...